Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Globus Medical GMED +0.38% Get Free Report has outperformed the market over the past 10 years by 1.4% on an annualized basis ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) on April 15 and set a price target ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have completely ...

Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...